Brief: Aft Pharmaceuticals Welcomes Dismissal Of Application By Reckitt & Benckiser To Appeal Comparative Advertising Judgement Handed Down In Dec 2021
08/04/2022 02:39
April 8 (Reuters) - AFT Pharmaceuticals Ltd AFT.NZ :
* WELCOMES DISMISSAL OF APPLICATION BY RECKITT & BENCKISER
TO
APPEAL COMPARATIVE ADVERTISING JUDGEMENT HANDED DOWN IN DEC 2021
* AUSTRALIAN COURT TURNED DOWN APPLICATION FOR APPEAL
AGAINST
JUDGEMENT ON AFT
* JUDGEMENT THAT FOUND AFT WAS JUSTIFIED IN MAKING SERIES OF
CLAIMS IN RELATION TO EFFICACY OF ITS MAXIGESIC PAIN RELIEF
TABLETS
* IN PROCESS OF LAUNCHING NUMBER OF MAXIGESIC ORAL DOSE FORM
LINE
EXTENSIONS - MAXIGESIC HOT DRINK SACHETS2 IN AUSTRALIAN MARKET
Further company coverage: AFT.NZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV